These studies indicated that the anti-obesity effects of CCC were accompanied by a significant decrease in phospho-Akt and PPARγ expression in HFD tissues, thus suggesting that CCC has the ability to prevent HFD-induced obesity, possibly through the activation of Akt and PPARγ signaling. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.